Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
The health care debate has Democrats on Capitol Hill and the presidential campaign trail facing renewed pressure to make clear where they stand: Are they for “Medicare for All”? Or will they take up the push to protect the Affordable Care Act?
Consumers want more information about healthcare costs and alternative options for receiving care. Providers and payers are already moving in that direction with expanded access to and coverage of telehealth. Efforts like Aetna's app for Apple Watch — which reminds users to fill prescriptions, get wellness checkups and immunizations and informs them of lower-cost options for lab tests and imaging — could increase satisfaction, giving people more control over their health and helping to reduce out-of-pocket spend.
The highly anticipated analysis released yesterday by a nonpartisan organization on Medicare-for-all told us this much: Transitioning the United States to such a single-payer health-care system would be messy. Very messy.
Forty percent of Americans with employer-sponsored health insurance struggle to pay for their health care costs, according to a new survey, and those with chronic conditions are especially hard hit.
The repeal of ObamaCare’s individual mandate will result in 7 million more people without health insurance by 2021, according to new estimates from the Congressional Budget Office (CBO).
Insurers are projected to submit rate increases in the Affordable Care Act market of about 10 percent, which is higher than the roughly 6 percent increase for 2019, according to Dave Dillon, a fellow of the Society of Actuaries and senior vice president of Lewis & Ellis, Actuaries and Consultants.
A key part of the Trump administration’s plan to lower the list prices of drugs wouldn’t actually do so and would end up increasing federal spending by tens of billions of dollars over a decade, the Congressional Budget Office said Thursday.
Yesterday at the World Medical Innovation Forum in Boston, Centers for Medicare and Medicaid Services Administrator Seema Verma argued that government can often foil innovation.
The Trump administration’s plan to end legal protections for drug rebates in a move to curb costs would actually boost Part D premiums and federal spending, according to the Congressional Budget Office.
If The Senior Citizens League is correct in its forecasts — and it has a strong record of that — roughly half of the Social Security cost-of-living adjustment (COLA) for 2020 for the average retiree will be wiped out by the increase in Medicare Part B premiums that year.